Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation of the Astral VAPS AutoEPAP Treatment Algorithm

NCT02683772 is registered in ClinicalTrials.gov with ResMed as lead sponsor.

NCT NCT02683772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02683772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation of the Astral VAPS AutoEPAP Treatment Algorithm
Lead sponsor
ResMed
Phase
Phase 3
Overall status
Completed
Start date
April 15, 2016
Completion date
July 6, 2017
Enrollment
42 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory failure, respiratory insufficiency, upper airway obstruction